Keyword Connections

drug administration

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

36

1 Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test

2 Multidrug-resistant malaria and the impact of mass drug administration

3 Multidrug-resistant malaria and the impact of mass drug administration

4 The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers

5 Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration

6 Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.

7 Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

8 Impact of a New Consumer Form on Adverse Event Reporting to the United States Food and Drug Administration.

9 Do drug package inserts meet the rules and regulations of Iran's Food and Drug Administration in terms of informing patients?

10 The History of the FDA's Fight for Consumer Protection and Public Health, by US Food and Drug Administration.

11 Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)

12 Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications with the US Food and Drug Administration

13 Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).

14 Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System.

15 Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research.

16 Re: Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes: C. Gan, S. Amery, K. Chatterton, M. S. Khan, K. Thomas and T. O'Brien J Urol 2016; 195: 1697–1703.

17 Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop

18 American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019

19 Mass drug administration for trachoma: how long is not long enough?

20 Principles in action: An examination of Food and Drug Administration letters involving violative internet promotions from 1997 to 2012

21 An optimal interval type-2 fuzzy logic control based closed-loop drug administration to regulate the mean arterial blood pressure

22 The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule

23 Vilazodone: Clinical Basis for the US Food and Drug Administration’s Approval of a New Antidepressant

24 Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

25 Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa

26 US Food and Drug Administration Regulations Governing Label Claims for Food Products, Including Probiotics

27 adherence to artesunate-amodiaquine therapy for uncomplicated malaria in rural ghana: a randomised trial of supervised versus unsupervised drug administration

28 effects of sharing information on drug administration errors in pediatric wards: a pre–post intervention study

29 inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices

30 postmarketing commitments for novel drugs and biologics approved by the us food and drug administration: a cross-sectional analysis

31 fingolimod: the first oral drug approved by food and drug administration; a breakthrough in treatment of multiple sclerosis

32 a comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis

33 End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration Perspective

34 Effect of Prenatal Drug Administration on Maternal and Neonatal Platelet Aggregation and PF4 Release

35 Effect of Prenatal Drug Administration on Maternal and Neonatal Platelet Aggregation and PF4 Release

36 Development of Magnetic Microbeads Equipped with Temperature-Responsive Artificial Antibodies for Efficient Anticancer Drug Administration.